Clinical Trials Logo

Hyponatremia clinical trials

View clinical trials related to Hyponatremia.

Filter by:

NCT ID: NCT01838759 Completed - Hyponatremia Clinical Trials

Bioimpedance Spectroscopy for the Differential Diagnosis of Hyponatremia

Start date: February 2013
Phase: N/A
Study type: Observational [Patient Registry]

We aimed to investigate the role of bioimpedance spectroscopy for the diagnosis of hyponatremia

NCT ID: NCT01556646 Completed - Cirrhosis Clinical Trials

Effect of Tolvaptan on Cognitive Function in Cirrhosis

Start date: April 2011
Phase: Phase 3
Study type: Interventional

Hypothesis: Tolvaptan will improve cognitive function, brain edema and health-related quality of life in cirrhotic patients with hyponatremia

NCT ID: NCT01456832 Completed - Hyponatremia Clinical Trials

Post Operative Hyponatremia in the Renal Transplant Population

Start date: January 2010
Phase: N/A
Study type: Observational

This study is designed to determine the causes of low sodium (salt) in the body fluids outside the cells for patients who have received a kidney transplant at the Mayo Clinic of Florida. The investigators will look at data collected on previous transplant patients at the Mayo Clinic to determine if the low sodium levels could be related to factors occurring in the course of surgery. The investigators hypothesize that the intravenous fluid used in the surgery, which is about half the concentration of normal saline, could contribute to the low sodium levels.

NCT ID: NCT01456533 Completed - Hyponatremia Clinical Trials

Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients

COMED
Start date: October 2011
Phase: N/A
Study type: Observational

Background: Hypo- and hypernatremia are common in hospitalized patients. The differential diagnosis of dysnatremia is challenging. Osmotically inadequate secretion of antidiuretic hormone (ADH) is the predominant mechanism in most dysnatremic disorders. ADH measurement is cumbersome. It is derived from a larger precursor peptide along with copeptin, which is a more stable peptide directly mirroring the production of ADH. Objective: To evaluate the additional value of copeptin to improve a currently used algorithm in the differential diagnosis of (A) severe hypoosmolar hypo- and (B) severe hypernatremia. Design: Prospective observational study.

NCT ID: NCT01370473 Completed - Hyponatremia Clinical Trials

Institutional Registry of Hyponatremia

Hyponatremia
Start date: December 2006
Phase:
Study type: Observational

The purpose of this study is to create an institutional and population-based registry of Hyponatremia with a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival. This study will also describe the occurrence of hyponatremia in the population of HIBA in the Central Hospital, as well as the characteristics of clinical presentation, evolution and predisposing factors of hyponatremia.

NCT ID: NCT01346891 Completed - Clinical trials for Thiazide Diuretics Induced Hyponatremia

Polymorphisms of the Thiazide's Receptor Gene SLC12A3 and Development of Hyponatremia

Start date: July 2010
Phase: N/A
Study type: Observational

The purpose of this study is to detect if there are any differences in the coding region of SLC12A3 gene in individuals who have had hyponatremia associated to the use of thiazides, and those thiazides consumers without hyponatremia that have demonstrated good tolerance to the drug.

NCT ID: NCT01341665 Completed - Hyponatremia Clinical Trials

Subclassification of the Syndrome of Inappropriate ADH Secretion

Start date: March 2008
Phase: N/A
Study type: Observational

The aim of this study is to evaluate the different types of osmotic dysregulation in patients with Syndrome of Inappropriate ADH (SIADH) and, hence, to analyze the pathophysiology of SIADH. These types will be characterized by measurement of AVP and copeptin while performing an osmotic stimulation with infusion of hypertonic saline.

NCT ID: NCT01301274 Completed - Hyponatremia Clinical Trials

0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children

NaCrICh
Start date: February 2011
Phase: N/A
Study type: Interventional

The primary objective of this study is to compare the mean serum sodium after 48 hours of therapy with either 0.45% NaCl/dextrose 5% or 0.9% NaCl/dextrose 5%, in critically ill children requiring IV maintenance fluid administration.

NCT ID: NCT01299779 Completed - Hyponatremia Clinical Trials

Incidence of Hyponatremia in PEG-SD Compared to PEG-ELS

Start date: June 2010
Phase: N/A
Study type: Interventional

Objective: To compare the incidence of peri-colonoscopy hyponatremia associated with PEG 3350 + sports drink (PEG-SD) versus PEG 3350-electrolyte solution + sodium sulfate + sodium ascorbate and ascorbic acid (PEG-ELS). Hypothesis: As compared to PEG-SD, hyponatremia occurs significantly less often with PEG-ELS.

NCT ID: NCT01251770 Completed - Hyponatremia Clinical Trials

Variation in Natremia Using Two Different Maintenance Intravenous Fluids in Postsurgical Hospitalized Children

surgical-Na
Start date: December 2010
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to compare the blood sodium level after 12 hours following the initiation of therapy with either 0.3% NaCl/dextrose 5% or 0.45% NaCl/dextrose 5%, in postsurgical hospitalized children requiring maintenance IV fluid administration.